Welcome to our dedicated page for Sabra Health Care REIT SEC filings (Ticker: SBRA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Sabra Health Care REIT, Inc. filings document the reporting obligations of a Nasdaq-listed healthcare REIT that owns and invests in healthcare real estate through subsidiaries. Its 8-K reports cover operating results, supplemental information packages, non-GAAP financial measure reconciliations, Regulation FD materials, capital-structure events and material definitive agreements.
Proxy materials describe board and shareholder governance for the Maryland corporation. Other disclosures address common stock listed under the SBRA symbol, equity distribution arrangements, debt redemption notices, related financing arrangements and risk or governance matters tied to the company’s REIT structure and healthcare real estate portfolio.
Barbarosh Craig A. reported acquisition or exercise transactions in this Form 4 filing.
Sabra Health Care REIT, Inc. director Craig A. Barbarosh reported an equity compensation grant rather than an open-market trade. He received 8,310 restricted stock units of common stock under the company’s 2009 Performance Incentive Plan at no cash cost.
The units vest in equal monthly installments beginning July 17, 2026 and continuing until the earlier of June 17, 2027 or the day before the next annual stockholders’ meeting. Following this grant, he holds 63,326 stock units directly, consisting of 8,310 unvested units and 55,016 vested units with payment deferred, each representing one share of common stock. He also reports 94,916 shares held indirectly through The Barbarosh Family Trust.
Sabra Health Care REIT, Inc. held its annual stockholder meeting on June 17, 2026. Stockholders elected seven directors to serve until the 2027 annual meeting and until their successors are elected and qualified.
They also ratified PricewaterhouseCoopers LLP as independent registered public accounting firm for the year ending December 31, 2026, with 226,576,585 votes for, 1,648,639 against and 173,917 abstentions. In addition, stockholders approved, on an advisory basis, the compensation of the company’s named executive officers, with 199,568,777 votes for, 7,867,562 against and 355,123 abstentions.
Malehorn Jeffrey A. reported acquisition or exercise transactions in this Form 4 filing.
Sabra Health Care REIT director Jeffrey A. Malehorn received 817 stock units as a compensation-related award. The units were credited as dividend equivalent payments on previously granted stock units under Sabra’s 2009 Performance Incentive Plan, with no cash paid by Malehorn. These new units vest and pay on the same schedule as the original awards.
After this grant, Malehorn directly holds 108,036 stock units or shares-linked units, including 726 unvested stock units and 54,290 vested stock units whose payment has been deferred. Each stock unit represents the right to receive one share of Sabra common stock.
Kono Ann reported acquisition or exercise transactions in this Form 4 filing.
Sabra Health Care REIT, Inc. director Ann Kono received an award of 817 common stock units on May 29, 2026. These units were credited as dividend equivalent payments on previously granted stock units under the company’s 2009 Performance Incentive Plan and carry no purchase price.
Each stock unit represents the right to receive one share of common stock and will vest and be paid on the same schedule as the original awards. Following this grant, Kono directly holds 59,876 stock units, including 726 unvested units and 54,290 vested units for which payment has been deferred.
Sabra Health Care REIT, Inc. director Lynne S. Katzmann received a grant of 817 stock units of common stock on May 29, 2026. The award was credited as dividend equivalent payments on previously granted stock units under the company’s 2009 Performance Incentive Plan and carries no cash exercise price.
Each stock unit represents the right to receive one share of common stock and will vest and be paid on the same terms as the original units they relate to. After this credit, Katzmann holds 77,811 stock units in total, including 726 unvested units and 54,290 vested units with payment deferred.
Sabra Health Care REIT director Michael J. Foster reported routine share and stock unit changes. He made a bona fide gift of 500 shares of common stock and received 817 additional stock units credited as dividend equivalent payments under the company’s 2009 Performance Incentive Plan.
After these transactions, he directly holds 73,733 shares of common stock and indirectly holds 42,411.745 shares through a 401(k) plan. Footnotes also note 726 unvested stock units and 54,290 vested but deferred stock units, each representing the right to receive one share of common stock.
Sabra Health Care REIT, Inc. director Catherine Cusack reported an acquisition of 817 stock units of Common Stock on the basis of dividend equivalent payments. These units were credited under the company’s 2009 Performance Incentive Plan at the market value on the dividend payment date.
Each stock unit represents the right to receive one share of Common Stock. After this grant, Cusack directly holds 73,746 stock units, including 726 unvested units and 54,290 units that have vested but for which payment has been deferred.
Barbarosh Craig A. reported acquisition or exercise transactions in this Form 4 filing.
Sabra Health Care REIT director Craig A. Barbarosh reported routine equity compensation rather than an open‑market trade. He received an award of 817 common stock units at a price of $0.0000 per unit, credited as dividend equivalent payments on previously granted stock units under Sabra’s 2009 Performance Incentive Plan.
Following this grant, Barbarosh holds 55,016 stock units directly and 94,916 shares indirectly through The Barbarosh Family Trust. The new units will vest and be paid on the same schedule as the original stock units they track, with each unit representing the right to receive one Sabra common share.
Sabra Health Care REIT, Inc. reported that Executive VP & CAO Jessica Flores acquired 385 shares of common stock on May 29, 2026 through a stock unit award valued at $0.00 per share. These stock units were credited as dividend equivalent payments on previously granted units under the company’s 2009 Performance Incentive Plan.
After this grant, she directly holds 72,094 shares of common stock in total. This amount includes 25,912 stock units that will be settled on a one-for-one basis in Sabra common shares, vesting on the same schedule as the original awards. The transaction reflects routine equity compensation rather than an open-market purchase or sale.
Sabra Health Care REIT, Inc. Executive VP, CIO & Secretary Darrin Smith reported a compensation-related stock grant. On May 29, 2026, he acquired 501 shares of Common Stock at no cost through stock units credited as dividend equivalent payments on previously granted units.
After this award, Smith directly holds 116,424 shares, including 33,687 stock units that will be settled one-for-one in common shares under the company’s 2009 Performance Incentive Plan. This filing reflects routine equity compensation rather than an open-market purchase or sale.